Trials / Unknown
UnknownNCT04489264
The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma
A Prospective Study of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
The role of autologous stem cell transplantation (ASCT) in the first remission (CR1 \& PR1) of peripheral T-cell lymphomas (PTCLs) is not well defined. This study analyzed the impact of ASCT on the clinical outcomes of patients with newly diagnosed PTCL in CR1 and PR1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Transplant, Autologous | high dose chemotherapy followed by autologous stem cell transplantation |
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2023-11-30
- Completion
- 2025-11-30
- First posted
- 2020-07-28
- Last updated
- 2020-12-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04489264. Inclusion in this directory is not an endorsement.